Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CALC Trial: Aprepitant for treatment of cough in lung cancer
2013-000139-28Phase 4Completed
- Sponsor
- The Christie
- Start
- Feb 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of aprepitant in bronchial carcinoma, sponsored by The Christie. Primary endpoint: Primary endpoint: change in cough count. Started Feb 2013; status: completed.
02
Drugs
aprepitant
03
Conditions
bronchial carcinoma
Beyond the preview
Go deeper on 2013-000139-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-000139-28.